ERICA CIRRINTANO: Open Payments
NPI 1639845316 · ROMEOVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,439 in 83 payments from 11 companies in 2025. Trend: 2023 $384 · 2024 $1,443 · 2025 $1,439
Food & beverage: $1,439
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $731 |
| Novartis Pharmaceuticals Corporation | 22 | $287 |
| Teva Pharmaceuticals USA, Inc. | 3 | $80 |
| Biogen, Inc. | 3 | $80 |
| Mallinckrodt Hospital Products Inc. | 2 | $70 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Merz Pharmaceuticals, LLC | 1 | $36 |
| TG Therapeutics, Inc. | 1 | $32 |
| Celgene Corporation | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: QULIPTA, KESIMPTA, UBRELVY, BOTOX, AJOVY, TYSABRI, ACTHAR, Dysport.
Industry payments across IL — which companies pay providers there.
